Lupus

Women from historically underrepresented communities have a higher risk of pregnancy complications. So Johnson & Johnson Innovation challenged researchers to propose potential solutions that aim to address this troubling healthcare disparity. These awardees just might be the game changers.

What do diseases like multiple myeloma and lupus have in common? They’re more prevalent in people of color—yet historically these patients have been left out of clinical research, often to dire health consequences. Learn how Johnson & Johnson is working to make the study of conditions like these more equitable.